Hestia Insight Inc. (HSTA)
OTCMKTS · Delayed Price · Currency is USD
0.1400
-0.0100 (-6.67%)
At close: Aug 6, 2025
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2016 - 2020 |
Operating Revenue | -0.03 | 1.25 | 0.11 | 0.02 | 0.03 | 0.11 | Upgrade |
Other Revenue | - | - | - | - | - | 0.03 | Upgrade |
| -0.03 | 1.25 | 0.11 | 0.02 | 0.03 | 0.14 | Upgrade | |
Revenue Growth (YoY) | - | 1002.06% | 656.09% | -47.37% | -80.05% | 19.04% | Upgrade |
Cost of Revenue | - | - | - | - | 0 | - | Upgrade |
Gross Profit | -0.03 | 1.25 | 0.11 | 0.02 | 0.03 | 0.14 | Upgrade |
Selling, General & Admin | 0.47 | 0.4 | 0.42 | 0.36 | 0.25 | 0.15 | Upgrade |
Operating Expenses | 0.47 | 0.4 | 0.42 | 0.36 | 0.25 | 0.15 | Upgrade |
Operating Income | -0.5 | 0.85 | -0.31 | -0.35 | -0.22 | -0.01 | Upgrade |
Interest Expense | -0.01 | -0 | - | - | - | -0 | Upgrade |
Interest & Investment Income | - | 0 | 0 | 0.01 | 0 | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | - | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | -0.52 | 0.85 | -0.3 | -0.34 | -0.22 | -0 | Upgrade |
Gain (Loss) on Sale of Investments | -0.53 | -0.12 | -0.12 | -1.37 | -9.55 | 11.53 | Upgrade |
Gain (Loss) on Sale of Assets | -0.01 | - | -0.07 | - | - | - | Upgrade |
Pretax Income | -1.06 | 0.73 | -0.5 | -1.71 | -9.77 | 11.52 | Upgrade |
Income Tax Expense | 0.09 | 0.09 | - | - | - | - | Upgrade |
Net Income | -1.15 | 0.64 | -0.5 | -1.71 | -9.77 | 11.52 | Upgrade |
Net Income to Common | -1.15 | 0.64 | -0.5 | -1.71 | -9.77 | 11.52 | Upgrade |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 28 | 28 | Upgrade |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 28 | 28 | Upgrade |
Shares Change (YoY) | - | - | 0.01% | -0.37% | -1.29% | 0.01% | Upgrade |
EPS (Basic) | -0.04 | 0.02 | -0.02 | -0.06 | -0.35 | 0.41 | Upgrade |
EPS (Diluted) | -0.04 | 0.02 | -0.02 | -0.06 | -0.35 | 0.41 | Upgrade |
Free Cash Flow | -1.35 | -0.17 | -0.28 | -0.46 | -0.21 | -0.01 | Upgrade |
Free Cash Flow Per Share | -0.05 | -0.01 | -0.01 | -0.02 | -0.01 | - | Upgrade |
Gross Margin | - | 100.00% | 100.00% | 100.00% | 94.81% | 100.00% | Upgrade |
Operating Margin | - | 68.13% | -270.55% | -2321.79% | -772.61% | -4.48% | Upgrade |
Profit Margin | - | 51.38% | -441.22% | -11426.14% | -34268.13% | 8067.53% | Upgrade |
Free Cash Flow Margin | - | -13.51% | -245.65% | -3074.33% | -735.80% | -9.43% | Upgrade |
EBITDA | -0.5 | 0.86 | -0.29 | -0.34 | - | - | Upgrade |
EBITDA Margin | - | 68.52% | -258.88% | - | - | - | Upgrade |
D&A For EBITDA | 0 | 0 | 0.01 | 0.01 | - | - | Upgrade |
EBIT | -0.5 | 0.85 | -0.31 | -0.35 | -0.22 | -0.01 | Upgrade |
EBIT Margin | - | 68.13% | -270.55% | - | - | -4.48% | Upgrade |
Effective Tax Rate | - | 12.52% | - | - | - | - | Upgrade |
Revenue as Reported | - | - | - | 0.02 | 0.03 | 0.14 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.